Lobbying Filing Details

Total Spending

$30,000

Activities

4

Lobbyists

2

Gov't Entities

12

Filing Information
Filing UUID:
2da97b0d-c875-41c4-ab62-b762434c2108
Type:
Q1 - 1st Quarter - Report
Period:
2019 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 18, 2019 at 8:46 PM
Income:
$30,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: K. LAURIE MCKAY
Registrant
GREENBERG TRAURIG, LLP

Law firm

Washington, District of Columbia
Client
AMERICAN SOCIETY INTERVENTIONAL PAIN PHYSICIANS

Professional trade organization focused on issues affecting interventional pain

Kentucky, United States of America
Lobbying Activities (4)
Activity 1
Budget/Appropriations

Outreach and monitoring related to the implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Outreach and monitoring related to federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60).
Outreach and monitoring related to federal and legislative activity related to Medicare Reimbursement.
Outreach and monitoring related to federal issues and legislation associated with health care policy.
Outreach and monitoring related to federal issues and legislation associated with opioids.

Lobbyists (2)
  • TIM HUTCHINSON
  • MONICA PRAHL SCHULTEIS
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Centers For Medicare and Medicaid Services (CMS)
Activity 2
Health Issues

Outreach and monitoring related to the implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Outreach and monitoring related to federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60).
Outreach and monitoring related to federal and legislative activity related to Medicare Reimbursement.
Outreach and monitoring related to federal issues and legislation associated with health care policy.
Outreach and monitoring related to federal issues and legislation associated with opioids.

Lobbyists (2)
  • TIM HUTCHINSON
  • MONICA PRAHL SCHULTEIS
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Centers For Medicare and Medicaid Services (CMS)
Activity 3
Medical/Disease Research/Clinical Labs

Outreach and monitoring related to the implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Outreach and monitoring related to federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60).
Outreach and monitoring related to federal and legislative activity related to Medicare Reimbursement.
Outreach and monitoring related to federal issues and legislation associated with health care policy.
Outreach and monitoring related to federal issues and legislation associated with opioids.

Lobbyists (2)
  • TIM HUTCHINSON
  • MONICA PRAHL SCHULTEIS
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Centers For Medicare and Medicaid Services (CMS)
Activity 4
Medicare/Medicaid

Outreach and monitoring related to the implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Outreach and monitoring related to federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60).
Outreach and monitoring related to federal and legislative activity related to Medicare Reimbursement.
Outreach and monitoring related to federal issues and legislation associated with health care policy.
Outreach and monitoring related to federal issues and legislation associated with opioids.

Lobbyists (2)
  • TIM HUTCHINSON
  • MONICA PRAHL SCHULTEIS
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Centers For Medicare and Medicaid Services (CMS)

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.